Morgan Stanley’s Apnimed APMD Stock Holding History
Bought
Maintained
Sold
Other funds holding APMD
TCM
Morgan Stanley's APMD Position: Q3 2026 in Review
Morgan Stanley opened a new position in Apnimed (APMD) in Q3 2026: 21,326 shares worth $467K. The stake represents ﹤0.01% of the portfolio and ranks #5642 among its holdings.
71 funds tracked by Wall St. Rank hold APMD as of Q3 2026.
- Morgan Stanley held 21,326 shares of Apnimed worth $467K as of Q3 2026.
- Apnimed was a new Morgan Stanley position in Q3 2026.
- Apnimed made up ﹤0.01% of Morgan Stanley's portfolio in Q3 2026, its #5642 holding.
- 71 funds tracked by Wall St. Rank held Apnimed as of Q3 2026.
Based on Morgan Stanley's 13F filing for Q3 2026, filed 13 Nov 2026.